Sangamo Therapeutics
SGMO
#6965
Rank
โ‚ฌ0.39 B
Marketcap
1,90ย โ‚ฌ
Share price
2.95%
Change (1 day)
396.46%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -โ‚ฌ0.2 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ12.27 Million. In 2023 the company made an earning of -โ‚ฌ0.12 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.2 Billion69.38%
2023 -โ‚ฌ0.12 Billion-40.88%
2022 -โ‚ฌ0.2 Billion9.79%
2021 -โ‚ฌ0.18 Billion41.52%
2020 -โ‚ฌ0.13 Billion23.17%
2019 -โ‚ฌ99.81 Million36.33%
2018 -โ‚ฌ73.21 Million36.89%
2017 -โ‚ฌ53.49 Million-22.32%
2016 -โ‚ฌ68.86 Million54.86%
2015 -โ‚ฌ44.47 Million75.62%
2014 -โ‚ฌ25.32 Million0.13%
2013 -โ‚ฌ25.29 Million
2011 -โ‚ฌ34 Million43.66%
2010 -โ‚ฌ23.67 Million28.52%
2009 -โ‚ฌ18.42 Million-23.55%
2008 -โ‚ฌ24.09 Million2.45%
2007 -โ‚ฌ23.51 Million19.5%
2006 -โ‚ฌ19.67 Million50.78%
2005 -โ‚ฌ13.05 Million75%
2004 -โ‚ฌ7.46 Million-33.25%
2003 -โ‚ฌ11.17 Million-62.27%
2002 -โ‚ฌ29.6 Million102.82%
2001 -โ‚ฌ14.6 Million23.21%
2000 -โ‚ฌ11.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ1.45 B-844.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.18 Billion-9.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.43 B-2,366.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.24 B-736.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.97 B-598.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.45 B-9,009.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.37 B-289.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.64 B-8,086.98%๐Ÿ‡บ๐Ÿ‡ธ USA